airmid healthgroup ltd

European research company study shows effectiveness of cleaning process in reducing allergen levels

Airmid healthgroup has announced today that it is expanding its range of microbiological services in the area of antimicrobial surface activity and biocidal efficacy.

AHG’s innovative techniques & facilities that identify, evaluate and address the potential hazardous nature of ultrafine particles has them well positioned to provide the necessary resources to the Filtration Industry.

The 11th World Filtration Congress will embrace the whole spectrum of filtration and separation technologies from around the world Airmid Healthgroup will be there.

Bluebear Nursery today released the findings from an allergen barrier efficacy study, undertaken on one of their leading baby mattress brands, ‘Aerosleep Baby Protect’. The study was conducted by Dublin-based airmid healthgroup.

airmid research team travel to the USA to present bio-medical research data related to indoor air quality and health at a world premiere medical event to expand knowledge in allergy, immunology and issues that relate to indoor air quality. .

airmid healthgroup ltd are delighted to announce the appointment of another PhD graduate, to their already multifaceted science team.

airmid healthgroup ltd, a world’s leading bio-medical research facility, have demonstrated their continued innovation growth with the appointment of Vivienne Mahon PhD as the new Senior Scientific Officer/Laboratory Research.

Dr John McKeon, co-Founder of airmid healthgroup ltd , was recently invited to be a guest speaker and sit on the judging panel at a post-doctoral workshop on Entrepreneurship as part of the Marie Curie International Training Network.

Members of the airmid healthgroup ltd research team were delighted to be invited by the Provost to attend a distinguished gathering as The Trinity Biomedical Sciences Institute was officially opened by the Prime Minister, Enda Kenny.